Le Lézard
Classified in: Health
Subjects: NPT, PER, VET

Special Forces Veteran Kevin Flike Appointed to The Green Beret Foundation Board Of Directors


SAN ANTONIO, Oct. 25, 2018 /PRNewswire/ -- The Green Beret Foundation, an organization dedicated to supporting soldiers of the U.S. Army Special Forces and their families, is pleased to announce the appointment of Retired Green Beret, SSG(R) Kevin Flike to its Board of Directors.

Kevin was assigned to the 1st Special Forces Group Airborne at Fort Lewis, Washington, where he deployed to the Philippines, Thailand and twice to Afghanistan. After sustaining a gunshot wound during combat operations in Afghanistan, Kevin medically retired on September 27, 2013.

Prior to enlisting in the US Army, Kevin attended Union College in Schenectady, New York where he attained a Bachelor of Arts in Political Science and a double minor in Mandarin Chinese and East Asian Studies. In 2016, after retiring from the Army, Kevin completed dual master's degrees from the MIT Sloan School of Management (MBA) and the Harvard Kennedy School of Government (MPA). Following his graduate studies, Kevin worked at Goldman Sachs for two years.  Currently, he is the Director of Strategic Projects for Threat Stack, a Boston-based cyber-security firm. Kevin will retain his position with Threat Stack while serving on the Board. Kevin has successfully translated the skillsets he learned as a Green Beret, such as innovative problem-solving, mentoring and leading, and developing cross- functional teams, into the workplace.

Kevin's military awards and decorations include the Bronze Star Medal (two awards), Purple Heart, Army Commendation Medal with Valor, Meritorious Service Medal, Afghan Campaign Medal, Airborne Parachutist Badge and the Combat Infantryman Badge.

"We are incredibly pleased to welcome Kevin to join the Green Beret Foundation's board and look forward to his contributions," said Jim Kester, Vice Chairman of the Green Beret Foundation Board of Directors. "Kevin is a model of perseverance and truly understands the complexity of what it means to be a Green Beret. His incredible educational background and work experience will be invaluable to the Foundation."

Since retiring from the military, Kevin remains committed to sharing his story of resilience and courage through speaking engagements and writing for his blog Wounded By War. Most recently, Kevin produced a first-of-its-kind documentary, which will debut on November 13th, called "Wounded By War." This video takes the audience through Kevin's journey, from the day of his injury, struggles with PTSD and his transition from being an active duty soldier moving into the private sector. 

"I am honored to join the Green Beret Foundation Board of Directors and uphold the mission of the Foundation," Kevin expressed. "The Green Beret Foundation was there to support me when I faced my toughest battles, and I will help continue this legacy for others."

About the Green Beret Foundation:

Founded in 2009, the Green Beret Foundation is a 501(c)(3) non-profit organization dedicated to the long-term health of the Green Beret community. The Foundation answers the call of the Green Berets and their families so that they can succeed in their next mission. Green Berets serve a little understood mission and face unique challenges when they come home. To aid in the transitions of Green Berets and their families, the Foundation provides casualty support, extended care support, family support and transition support. For more information, visit: www.greenberetfoundation.org.

 

SOURCE Green Beret Foundation


These press releases may also interest you

at 08:25
NOVA LEAP HEALTH CORP. ("Nova Leap" or "the Company"), a growing home health care organization, is pleased to announce that it has executed a definitive agreement (the "Agreement"), dated April 25, 2024, to acquire a home care services company ("the...

at 08:20
Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Dr. Stanley Appel, M.D., Chairman of Coya's Scientific Advisory...

at 08:19
Nitto Denko Avecia Inc. and Nitto Denko Avecia Pharma Services (Nitto Avecia), a global leader in contract development and manufacturing of oligonucleotides for the therapeutic market announced today that Tammy Cooper will be appointed President of...

at 08:05
Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide...

at 08:05
Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (MDNAF: OTCQB), a clinical-stage immunotherapy company focused on the development of engineered cytokines, today announced a CA$20 million investment by RA Capital Management, a multi-stage...

at 08:02
Sobi® today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending approval of efanesoctocog alfa, for the treatment and prevention of bleeds and perioperative...



News published on and distributed by: